UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients

Gastroenterology (New York, N.Y. 1943), 1997-02, Vol.112 (2), p.463-472

1997

Volltextzugriff (PDF)

Reduction of relapse rates by 18-month treatment in chronic hepatitis C. A Benelux randomized trial in 300 patients

Journal of hepatology, 2004-04, Vol.40 (4), p.689-695

2004

Volltextzugriff (PDF)

Review article : glycyrrhizin as a potential treatment for chronic hepatitis C

Alimentary pharmacology & therapeutics, 1998-03, Vol.12 (3), p.199-205

1998

Volltextzugriff (PDF)

Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: Meta-analysis of individual patient data from European centers

Journal of hepatology, 1997-05, Vol.26 (5), p.961-966

1997

Volltextzugriff (PDF)

Intravenous glycyrrhizin for the treatment of chronic hepatitis C: A double-blind, randomized, placebo-controlled phase I/II trial

Journal of gastroenterology and hepatology, 1999-11, Vol.14 (11), p.1093-1099

1999

Volltextzugriff (PDF)

Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials

Gastroenterology (New York, N.Y. 1943), 1999-08, Vol.117 (2), p.408-413

1999

Volltextzugriff (PDF)

Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C

Journal of hepatology, 1997-07, Vol.27 (1), p.201-205

1997

Volltextzugriff (PDF)

A psychometric comparison of health-related quality of life measures in chronic liver disease

Journal of clinical epidemiology, 2001-06, Vol.54 (6), p.587-596

2001

Volltextzugriff (PDF)

Estimation of early hepatitis C viral clearance in patients receiving daily interferon and ribavirin therapy using a mathematical model

Hepatology (Baltimore, Md.), 2001-02, Vol.33 (2), p.419-423

2001

Volltextzugriff (PDF)

Hyperpigmentation during interferon‐alpha therapy for chronic hepatitis C virus infection

British journal of dermatology (1951), 2003-08, Vol.149 (2), p.390-394

2003

Volltextzugriff (PDF)

Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study

Nephrology, dialysis, transplantation, 2001-01, Vol.16 (1), p.193-195

2001

Volltextzugriff (PDF)

Suicide associated with alfa-interferon therapy for chronic viral hepatitis

Journal of hepatology, 1994-08, Vol.21 (2), p.241-243

1994

Volltextzugriff (PDF)

Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C : HCV RNA at 4 weeks versus ALT

Journal of hepatology, 1999-02, Vol.30 (2), p.192-198

1999

Volltextzugriff (PDF)

Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy

Journal of hepatology, 1998-06, Vol.28 (6), p.960-964

1998

Volltextzugriff (PDF)

Prospective comparative study of spiral computer tomography and magnetic resonance imaging for detection of hepatocellular carcinoma

Gut, 2002-07, Vol.51 (1), p.105-107

2002

Volltextzugriff (PDF)

Therapy of hepatitis C: Patients with cirrhosis

Hepatology (Baltimore, Md.), 1997-09, Vol.26 (S3), p.128S-132S

1997

Volltextzugriff (PDF)

Peginterferon and dose-titrated ribavirin for hepatitis C-associated nephrotic membranoproliferative glomerulonephritis type 1

Digestive diseases and sciences, 2005-10, Vol.50 (10), p.1804-1806

2005

Volltextzugriff (PDF)

Acute pancreatitis attributed to the use of interferon alfa-2b

Gastroenterology (New York, N.Y. 1943), 2000-07, Vol.119 (1), p.230-233

2000

Volltextzugriff (PDF)

Bias and random error in retinol measurements of laboratories in countries with populations with mild to severe vitamin A deficiency

Clinical chemistry (Baltimore, Md.), 2002-11, Vol.48 (11), p.2061-2063

2002

Volltextzugriff (PDF)

High sustained virological response in chronic hepatitis C by combining induction and prolonged maintenance therapy

Journal of viral hepatitis, 2003-05, Vol.10 (3), p.205-209

2003

Volltextzugriff (PDF)

Retreatment of hepatitis C non-responsive to interferon. A placebo controlled randomized trial of ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378]

BMC gastroenterology, 2003-08, Vol.3 (1), p.24-24, Article 24

2003

Volltextzugriff (PDF)

Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients

Journal of hepatology, 1998-06, Vol.28 (6), p.951-959

1998

Volltextzugriff (PDF)

Monitoring intrahepatic CD8+ T cells by fine-needle aspiration cytology in chronic hepatitis C infection

Journal of viral hepatitis, 2004-07, Vol.11 (4), p.342-348

2004

Volltextzugriff (PDF)

New treatment strategies in non-responder patients with chronic hepatitis C

Journal of hepatology, 1999, Vol.31, p.184-188

1999

Volltextzugriff (PDF)

Hepatitis C: Viral kinetics

Hepatology (Baltimore, Md.), 1997-12, Vol.26 (6), p.1691-1693

1997

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(42)
Science & Technology
(42)
Humans
(36)
Biological And Medical Sciences
(31)
Medical Sciences
(30)
Gastroenterology & Hepatology
(27)
Middle Aged
(19)
Infectious Diseases
(18)
Adult
(17)
Female
(17)
Male
(16)
Antiviral Agents - Therapeutic Use
(15)
Interferon-Alpha - Therapeutic Use
(14)
Drug Therapy, Combination
(13)
Hepatitis C, Chronic - Drug Therapy
(13)
Human Viral Diseases
(13)
Recombinant Proteins
(13)
Viral Diseases
(13)
Viral Hepatitis
(13)
Pharmacology. Drug Treatments
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients

Reduction of relapse rates by 18-month treatment in chronic hepatitis C. A Benelux randomized trial in 300 patients

Review article : glycyrrhizin as a potential treatment for chronic hepatitis C

Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: Meta-analysis of individual patient data from European centers

Intravenous glycyrrhizin for the treatment of chronic hepatitis C: A double-blind, randomized, placebo-controlled phase I/II trial

Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials

Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C

A psychometric comparison of health-related quality of life measures in chronic liver disease

Estimation of early hepatitis C viral clearance in patients receiving daily interferon and ribavirin therapy using a mathematical model

Hyperpigmentation during interferon‐alpha therapy for chronic hepatitis C virus infection

Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study

Suicide associated with alfa-interferon therapy for chronic viral hepatitis

Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C : HCV RNA at 4 weeks versus ALT

Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy

Prospective comparative study of spiral computer tomography and magnetic resonance imaging for detection of hepatocellular carcinoma

Therapy of hepatitis C: Patients with cirrhosis

Peginterferon and dose-titrated ribavirin for hepatitis C-associated nephrotic membranoproliferative glomerulonephritis type 1

Acute pancreatitis attributed to the use of interferon alfa-2b

Bias and random error in retinol measurements of laboratories in countries with populations with mild to severe vitamin A deficiency

High sustained virological response in chronic hepatitis C by combining induction and prolonged maintenance therapy

Retreatment of hepatitis C non-responsive to interferon. A placebo controlled randomized trial of ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378]

Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients

Monitoring intrahepatic CD8+ T cells by fine-needle aspiration cytology in chronic hepatitis C infection

New treatment strategies in non-responder patients with chronic hepatitis C

Hepatitis C: Viral kinetics

Suchergebnisse filtern